Daewoong Pharmaceutical and LSK Global PS”Fight Son’ and Covid-19 treatment joint clinical development cooperation
Daewoong Pharmaceutical’s’Hoystar tablet’ approved for phase 3 clinical trials for COVID-19 prevention effect
Export of new drug technologies supported by the Ministry of Health and Welfare 6.8 trillion… Largest ever
Hanmi Pharm 2 innovative new drugs for rare disease treatment… FDA approval for Phase 2 clinical trial
Hanmi Pharm received FDA approval for Phase 2 clinical trials of two new drug candidates for rare diseases
The US FDA approves Phase 2 clinical trials of two innovative new drugs for rare disease treatment by Hanmi Pharmaceutical
NovaVax vaccine, which the Korean government is pursuing to pre-purchase, is’perplexed’ due to the departure of clinical participants in the US